A belief managed by 23andMe co-founder Anne Wojcicki has formally filed to take the genetic testing agency personal, providing to buy all shares of the agency for 40 cents per share, the present inventory value.
The deal, which Wojcicki had beforehand telegraphed, was made public in a submitting with the Securities and Alternate Fee on Wednesday; the proposal was made to a particular committee of 23andMe’s board on Monday. The submitting mentioned the deal would have to be authorised by the committee and 23andMe’s shareholders.
“I proceed to be enthusiastic about our mission of bettering the well being of thousands and thousands of individuals worldwide by means of the ability of genetics,” Wojcicki wrote in a letter accompanying the submitting. “We have now constructed a extremely useful, broadly acknowledged shopper model with one of many world’s largest and most various genetic datasets. As CEO, I stay as dedicated as ever to our long-term imaginative and prescient of changing into a world chief in genetics and establishing genetics as a mainstay of healthcare ecosystems worldwide.”
This text is unique to STAT+ subscribers
Unlock this text — and get further evaluation of the applied sciences disrupting well being care — by subscribing to STAT+.
Have already got an account? Log in
Have already got an account? Log in
View All Plans
